Pathway IV gene therapy(Mirus)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePathway IV gene therapy(Mirus)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionAngiogenesis stimulants
TargetsUpdating
Therapy Area/IndicationsIschemiaPeripheral Vascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMirus Bio LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMirus Bio LLC
Active IndicationsN/A
Inactive IndicationsIschemiaPeripheral Vascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A